An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Items 101–200 of 548
Sphingosine-1-phosphate pathway in renal fibrosis
Zhang, X., Ritter, J. K., & Li, N. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00596.2017 · Cited by 49
Muse Cells Are Endogenous Reparative Stem Cells
Kushida, Y., Wakao, S., & Dezawa, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56847-6_3 · Cited by 50
Endogenous agonist–bound S1PR3 structure reveals determinants of G protein–subtype bias
Maeda, S., Shiimura, Y., Asada, H., Hirata, K., Luo, F., Nango, E., Tanaka, N., Toyomoto, M., Inoue, A., Aoki, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf5325 · Cited by 50
“To eliminate antibodies recognizing flexible loops, N and C termini, or unstructured regions of S1PR3, we performed the same experiments using S1PR3 (2-330) denatured with 1% sodium dodecyl sulfate.”
MethodInfluentialCurrent and Novel Therapies for Eosinophilic Gastrointestinal Diseases
Marasco, G., Visaggi, P., Vassallo, M., Fiocca, M., Cremon, C., Barbaro, M. R., de Bortoli, N., Bellini, M., Stanghellini, V., Savarino, E. V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015165 · Cited by 51
“Sphingosine 1-Phosphate [S1P] Receptor S1P receptor modulation has been investigated as a potential treatment pathway for a number of immune-mediated conditions; it modulates a wide range of biological functions, including lymphocyte trafficking and endothelial barrier integrity [90].”
BackgroundModulation of sphingosine-1-phosphate in ulcerative colitis
ARGOLLO, M. C., Furfaro, F., Gilardi, D., Roda, G., Allocca, M., Peyrin‐Biroulet, L., & Danese, S. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1732919 · Cited by 48
“Among those, S1P1-3R1-3 are widely expressed, whereas the expression of S1P4R4 and S1P5R5 receptors is restricted to distinct cell types [18].”
BackgroundBernacchioni, C., Capezzuoli, T., Vannuzzi, V., Malentacchi, F., Castiglione, F., Cencetti, F., Ceccaroni, M., Donati, C., Bruni, P., & Petraglia, F. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.012 · Cited by 52
Cao, R., Li, J., Kharel, Y., Zhang, C., Morris, E., Santos, W. L., Lynch, K. R., Zuo, Z., & Hu, S. (2018) · Theranostics · doi:10.7150/thno.29435 · Cited by 47
“Recent studies have shown that elevated S1P is vasoprotective and neuroprotective [10] and that S1P promotes increased erythrocyte 2,3-bisphosphoglycerate and thus oxygen release as an adaptation to hypoxia [11], suggesting that the neuroprotective effect induced by the elevated S1P may be associated with cerebral hem…”
BackgroundMacrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling
Hutami, I. R., Izawa, T., Khurel‐Ochir, T., Sakamaki, T., Iwasa, A., & Tanaka, E. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168992 · Cited by 50
Childress, E. S., Kharel, Y., Brown, A. M., Bevan, D. R., Lynch, K. R., & Santos, W. L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00233 · Cited by 46
“tert-butyl (S)-2-((3-(4-(2,2,2-trifluoroacetamido)phenyl)-1,2,4-oxadiazol-5yl)methyl)pyrrolidine-1-carboxylate (15): Synthesized by General Procedure B.”
BackgroundLipidPedia: a comprehensive lipid knowledgebase
Kuo, T.-C., & Tseng, Y. J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty213 · Cited by 50
Lee, S.-H., Veeriah, V., & Levine, F. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03862-x · Cited by 45
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
Piccoli, M., Cirillo, F., Ghiroldi, A., Rota, P., Coviello, S., Tarantino, A., Rocca, P. L., Lavota, I., Creo, P., Signorelli, P., et al. (2023) · Antioxidants · doi:10.3390/antiox12010143 · Cited by 53
Zhu, Z., Zhang, L., Elsherbini, A. M., Crivelli, S. M., Tripathi, P., Harper, C., Quadri, Z., Spassieva, S. D., & Bieberich, E. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104713 · Cited by 54
Fettel, J., Kuhn, B. R., Guillen, N., Sürün, D., Peters, M., Bauer, R., Angioni, C., Geißlinger, G., Schnütgen, F., zu Heringdorf, D. M., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800221r · Cited by 45
“Furthermore, inhibition was only observed with S1P4-expressing cells; thus, the antiinflammatory effects of S1P are restricted to cells expressing both 5-LO and S1P4 such as leukocytes, monocytes/ macrophages, dendritic cells, or B lymphocytes (6, 10).”
BackgroundSphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
Vestri, A., Pierucci, F., Frati, A., Monaco, L., & Meacci, E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00296 · Cited by 45
“Sphingosine 1-phosphate receptors are widely expressed and specifically coupled to distinct G-proteins as reported in Table 1 (Blaho and Hla, 2014; Kihara et al., 2014; Pyne et al., 2015).”
BackgroundBinder, B. Y. K., Williams, P. A., Silva, E. A., & Leach, J. K. (2015) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2015.0107 · Cited by 45
“While S1PR1 activation has been shown to inhibit VEGF-induced hyperpermeability and aberrant sprouting,(64,65) S1PR3 conversely enhances vessel permeability and remodeling.(35,66) Thus, temporal regulation of S1P signaling is imperative for dictating the overall outcome.”
BackgroundIntegrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease
Su, F., Su, M., Wei, W., Wu, J., Chen, L., Sun, X., Liu, M., Sun, S., Mao, R., Bourgonje, A. R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2476570 · Cited by 44
“63 Reduced lymphocyte egress leads to a lower number of circulating lymphocytes in the bloodstream, which subsequently results in decreased inflammation and less tissue damage.”
Urine Metabonomics Reveals Early Biomarkers in Diabetic Cognitive Dysfunction
Song, L., Zhuang, P., Lin, M., Kang, M., Liu, H., Zhang, Y., Yang, Z. Y., Chen, Y., & Zhang, Y. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00168 · Cited by 45
Pépin, É., Jalinier, T., Lemieux, G. L., Massicotte, G., & Cyr, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00077 · Cited by 45
Wang, J., Goren, I., Yang, B., Lin, S., Li, J., Elias, M. G., Fiocchi, C., & Rieder, F. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16741 · Cited by 45
Sukocheva, O. A., Неганова, М. Е., Aleksandrova, Y. R., Burcher, J. T., Chugunova, E., Fan, R., Tse, E., Sethi, G., Bishayee, A., & Liu, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01626-6 · Cited by 43
“For instance, S1P receptor 1 (S1P1) transmits S1P effects in various immune cells and regulates egress of lymphocytes into the circulation from the spleen and lymph nodes (LNs) [265].”
BackgroundMacRitchie, N. A., Volpert, G., Washih, M. A., Watson, D. G., Futerman, A. H., Kennedy, S., Pyne, S., & Pyne, N. J. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.014 · Cited by 44
“The S1P formed by these enzymes can either be exported from cells (through transporter proteins e.g. Spns2) and bind to a family of five S1P-specific G protein coupled receptors (S1P1–5) [1,2] or can interact with specific intracellular target proteins.”
Yamamoto, R., Aoki, T., Koseki, H., Fukuda, M., Hirose, J., Tsuji, K., Takizawa, K., Nakamura, S., Miyata, H., Hamakawa, N., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13820 · Cited by 44
“ASP4058 stimulates S1P1 and S1P5 receptors with almost the same EC50 values (7.4 and 7.5 nM, respectively), but its potency for other S1P receptor subtypes is at least 100 times less (Table 1) (Yamamoto et al., 2014).”
BackgroundInfluential‘Crystal’ Clear? Lysophospholipid Receptor Structure Insights and Controversies
Blaho, V. A., & Chun, J. J. M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.08.006 · Cited by 42
“The known physiological roles of S1P and LPA are diverse, affecting activity of every mammalian organ system [2, 3, 6].”
BackgroundSelf-citationPotì, F., Ceglarek, U., Burkhardt, R., Simoni, M., & Nofer, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.020 · Cited by 42
“S1P exerts biological functions extracellularly through five cell surface G protein-coupled receptors termed S1P1eS1P5 [3].”
Tsai, C., Yang, D., Lin, C., Chen, T., Tang, C., & Huang, Y. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12106 · Cited by 40
“S1P can either be exported through the membranous specific transporter proteins and act as an extracellular first messenger ligand for its specific G protein-coupled receptors (S1P1–5) (Blaho and Hla, 2014) or can serve as an intracellular second messenger to bind to the specific intracellular target proteins (Hait et…”
BackgroundSphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
Roggeri, A., Schepers, M., Tiane, A., Rombaut, B., van Veggel, L., Hellings, N., Prickaerts, J., Pittaluga, A., & Vanmierlo, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207537 · Cited by 39
“For instance, the endothelial cells of the BBB express S1PR1, S1PR3, and S1PR5, which contribute to maintain BBB integrity and prevent vascular permeability [81,82].”
BackgroundImplication of sphingosin-1-phosphate in cardiovascular regulation
Li, N., & Zhang, F. (2016) · Frontiers in bioscience · doi:10.2741/4458 · Cited by 40
Lee, H. M., Lo, K. W., Wei, W., Tsao, S. W., Chung, G. T. Y., Ibrahim, M., Dawson, W. O., Murray, P. G., Paterson, I. C., & Yap, L. F. (2017) · The Journal of Pathology · doi:10.1002/path.4879 · Cited by 39
“S1P signalling affects many processes involved in carcinogenesis and there is now a growing appreciation that the oncogenic effects of S1P are dependent on the enzymes that generate or degrade S1P, and/or alterations in the expression of S1P receptors [7,11].”
BackgroundArlt, O., Schwiebs, A., Japtok, L., Rüger, K., Katzy, E., Kleuser, B., & Radeke, H. H. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362982 · Cited by 41
Horizon scanning: new and future therapies in the management of inflammatory bowel disease
Kumar, A., & Smith, P. J. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100012 · Cited by 39
Elburi, A. H. A., Adams, D. R., Smith, D. H., Tate, R. J., Mullin, M., Pyne, S., & Pyne, N. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25658 · Cited by 38
Ichiki, T., Koga, T., Okuno, T., Saeki, K., Yamamoto, Y., Yamamoto, H., Sakaguchi, M., & Yokomizo, T. (2016) · The FASEB Journal · doi:10.1096/fj.201500117 · Cited by 39
“The vascular S1P gradient is necessary for lymphocyte trafficking via the chemotactic activity of S1P1 (66, 68).”
BackgroundBernacchioni, C., Ghini, V., Cencetti, F., Japtok, L., Donati, C., Bruni, P., & Turano, P. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12048 · Cited by 39
“The activation of Akt is often detected following membrane receptor(s) engagement and is implicated in different S1PR downstream signaling (Blaho and Hla, 2014), suggesting that the here observed increased phosphorylation of Akt may rely on the engagement of S1PR through SK1-derived S1P, according…”
BackgroundNg, M. L., Yarla, N. S., Menschikowski, M., & Sukocheva, O. A. (2018) · World Journal of Stem Cells · doi:10.4252/wjsc.v10.i9.119 · Cited by 37
Sphingosine kinase 2 is a negative regulator of inflammatory macrophage activation
Weigert, A., von Knethen, A., Thomas, D., de Faria, I. C. J., Namgaladze, D., Zezina, E. A., Fuhrmann, D. C., Petcherski, A., zu Heringdorf, D. M., Radeke, H. H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.05.008 · Cited by 39
S1P Signaling in the Tumor Microenvironment
Schneider, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35582-1_7 · Cited by 39
Vito, C. D., Hadi, L. A., Navone, S. E., Marfia, G., Campanella, R., Mancuso, M. E., & Riboni, L. (2016) · Platelets · doi:10.3109/09537104.2016.1144179 · Cited by 41
Chen, T., Xue, H., Lin, R., & Huang, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.043 · Cited by 37
“Moreover, S1PR2 had inhibition on the endothelial barrier function[12], but the role of S 1PR2 in IBD has not been reported.”
BackgroundPrice, S. T. (2015) · International Journal of Stem cell Research & Therapy · doi:10.23937/2469-570x/1410014 · Cited by 36
“S1PR2 has additionally been shown to have essential functions in cell proliferation and survival, endothelial cell barrier function, mast cell activation, and auditory development [31,32].”
BackgroundIgawa, S., Choi, J. E., Wang, Z., Chang, Y.-L., Wu, C., Werbel, T., Ishida‐Yamamoto, A., & Nardo, A. D. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.010 · Cited by 38
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages
Bryan, A. M., You, J. K., McQuiston, T. J., Lazzarini, C., Qiu, Z., Sheridan, B. S., Nuesslein‐Hildesheim, B., & Poeta, M. D. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136068 · Cited by 39
Alkaline ceramidase family: The first two decades
Xu, R., Boasiako, P. A., & Mao, C. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109860 · Cited by 38
Treatments of inflammatory bowel disease toward personalized medicine
Kim, K., Kim, J., Kim, W.-H., Min, H., & Choi, C. H. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01318-6 · Cited by 40
Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine‐1‐Phosphate
Gaudio, I. D., Rubinelli, L., Sasset, L., Wadsack, C., Hla, T., & Lorenzo, A. D. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021261 · Cited by 38
Self-citationQu, S., Chen, L., Wen, X., Zuo, J., Wang, X., Zhijie, L., & Yang, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111116 · Cited by 41
A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
Burtscher, J., Maglione, V., Pardo, A. D., Millet, G. P., Schwarzer, C., & Zangrandi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020582 · Cited by 37
Ruiz, M., Devkota, R., Panagaki, D., Bergh, P., Kaper, D., Henricsson, M., Nik, A. M., Petkevicius, K., Höög, J. L., Bohlooly‐Y, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34931-0 · Cited by 39
Iwasawa, E., Ishibashi, S., Suzuki, M., Li, F., Ichijo, M., Miki, K., & Yokota, T. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.11.040 · Cited by 38
Sphingosine 1-Phosphate as a Link between Blood Coagulation and Inflammation
Rauch, B. H. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362994 · Cited by 36
Jiang, H., Shen, S.-M., Yin, J., Zhang, P., & Shi, Y. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175188 · Cited by 35
Schertz, H., Dänicke, S., Frahm, J., Schatzmayr, D., Dohnal, I., Bichl, G., Schwartz, H., Colicchia, S., Breves, G., Teifke, J. P., et al. (2018) · Toxins · doi:10.3390/toxins10070296 · Cited by 34
“S-1-P was already reported to elicit a G-protein coupled second messenger response in various tissues such as the vascular, nervous, or immune system [35,36].”
BackgroundPost-translational modifications of S1PR1 and endothelial barrier regulation
Anwar, M., & Mehta, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158760 · Cited by 39
“S1PRs 1–3 are highly expressed and distributed widely in immune, cardiovascular and nervous systems [10].”
BackgroundJiang, H., Joshi, S., Liu, H., Mansor, S., Qiu, L., Zhao, H., Whitehead, T., Gropler, R. J., Wu, G. F., Cross, A. H., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00492 · Cited by 36
Choden, T., Cohen, N. A., & Rubin, D. T. (2022) · PubMed Central · Cited by 34
Sphingosine-1-Phosphate Is a Crucial Signal for Migration of Retina Müller Glial Cells
Simón, M. V., Spalm, F. H. P., Politi, L. E., & Rotstein, N. P. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16195 · Cited by 34
“11,12 Sphingosine-1-phosphate is secreted from the cells by specific transporters to signal through its receptors in a paracrine or autocrine manner, named ‘‘ inside-out ’’ signaling.”
BackgroundWeske, S., Vaidya, M., Lipinski, K. V. W., Keul, P., Kristina, M., Burkhart, C., Haberhauer, G., Heusch, G., & Levkau, B. (2019) · Bone · doi:10.1016/j.bone.2019.04.015 · Cited by 36
Sphingosine Kinase 1: A Potential Therapeutic Target in Pulmonary Arterial Hypertension?
Pyne, N. J., & Pyne, S. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.07.001 · Cited by 35
“S1P can either be exported from cells and bind to a family of five S1Pspecific G protein coupled receptors (S1P1-5) [12, 13] or can interact with intracellular proteins, such as human HDAC-1/2 [14] to induce biological and cellular regulation.”
BackgroundMammoliti, O., Palisse, A., Joannesse, C., Bkassiny, S. E., Allart, B., Jaunet, A., Menet, C. J., Coornaert, B., Sonck, K., Duys, I., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00138 · Cited by 35
Hansen, L., Lohfink, N., Vutukuri, R., Kestner, R.-I., Trautmann, S., Hecht, M., Wagner, P. V., Spitzer, D., Khel, M. I., Macas, J., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0188-21.2021 · Cited by 34
Liao, J., Zheng, Y., Hu, M., Xu, P., Lin, L., Liu, X., Wu, Y., Huang, B., Ye, X., Li, S., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18363 · Cited by 34
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Kumar, A., Nema, R., Vishwakarma, S., Agarwal, R., & Panday, R. K. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99989 · Cited by 39
“HDL-bound S1P restrains lymphopoiesis and neuroinflammation by activating S1PR1 on bone marrow lymphocyte progenitors.(39) Several investigators have explored the potential of plasma S1P to serve as a biomarker for the detection of cancer.”
Meng, G., Tang, X., Yang, Z., Zhao, Y., Curtis, J. M., McMullen, T. P. W., & Brindley, D. N. (2018) · The FASEB Journal · doi:10.1096/fj.201801226r · Cited by 32
The Role of Sphingolipids in Allergic Disorders
Díaz‐Perales, A., Escribese, M. M., Garrido‐Arandia, M., Obeso, D., Izquierdo, E., Tomé‐Amat, J., & Barber, D. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.675557 · Cited by 33
“Furthermore, it is related to the activation of PI3K and PKC pathways (29).”
BackgroundChen, R., Zeng, Y., Xiao, W., Zhang, L., & Shu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665309 · Cited by 37
G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier
Pluimer, B. R., Colt, M., & Zhao, Z. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00139 · Cited by 36
“All members of the S1PR subfamily bind sphingosine 1-phosphate (S1P), a lysophospholipid that is highly concentrated in the blood and lymph plasma (Blaho and Hla, 2014).”
BackgroundInfluentialGowda, S. G. B., Gowda, D., Kain, V., Chiba, H., Hui, S., Chalfant, C. E., Parcha, V., Arora, P. K., & Halade, G. V. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00314.2021 · Cited by 36
Jung, Y., Lopez-Benitez, J., Tognoni, C. M., Carreras, I., & Dedeoglu, A. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148171 · Cited by 35
Elzoheiry, M., Da’dara, A. A., Bhardwaj, R., Wang, Q., Azab, M. S., El-Kholy, E.-S. I., El-Beshbishi, S. N., & Skelly, P. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01746 · Cited by 32
“S1P triggers a family of G-protein-coupled receptors to initiate signaling pathways that drive these processes (24).”
BackgroundLeBlanc, F., Pearson, J. M., Tan, S., Cheon, H., Xing, J. C., Dunton, W., Feith, D. J., & Loughran, T. P. (2020) · British Journal of Haematology · doi:10.1111/bjh.16530 · Cited by 34
“Additionally, the role of extracellular versus intracellular S1P and the involvement of S1PRs are actively being studied (Blaho & Hla, 2014).”
BackgroundCombined Signature of the Urinary Microbiome and Metabolome in Patients With Interstitial Cystitis
Xu, H., Tamrat, N. E., Gao, J., Xu, J., Zhou, Y., Zhang, S., Chen, Z., Shao, Y., Ding, L., Shen, B., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.711746 · Cited by 35
“S1P binds to its five G protein-coupled receptors to further activate a series of signaling pathways intracellularly and inside the nucleus, thereby affecting the transcription and protein translation (Blaho and Hla, 2014).”
BackgroundHaass, N. K., Nassif, N. T., & McGowan, E. M. (2015) · BioMed Research International · doi:10.1155/2015/165105 · Cited by 34
Lasa, J. S., Olivera, P. A., Bonovas, S., Danese, S., & Peyrin‐Biroulet, L. (2021) · Drug Safety · doi:10.1007/s40264-021-01057-z · Cited by 30
“As previously mentioned, there are five types of S1P receptors; S1P1, S1P2, and S1P3 are widely expressed, whereas S1P4 and S1P5 are restricted to specific cell types [3].”
BackgroundS1P and plasmalogen derived fatty aldehydes in cellular signaling and functions
Ebenezer, D. L., Fu, P., Ramchandran, R., Ha, A. W., Putherickal, V., Sudhadevi, T., Harijith, A. K., Schumacher, F., Kleuser, B., & Natarajan, V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158681 · Cited by 29
“[33], a naturally occurring bioactive lipid mediator that signals via S1P1–5 G-protein coupled receptors [34] [35].”
BackgroundLysolipids in Vascular Development, Biology, and Disease
Engelbrecht, E., MacRae, C. A., & Hla, T. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.305565 · Cited by 33
Self-citationOxysterols and multiple sclerosis: Physiopathology, evolutive biomarkers and therapeutic strategy
Véjux, A., Ghzaiel, I., Nury, T., Schneider, V., Charrière, K., Sghaier, R., Zarrouk, A., Leoni, V., Moreau, T., & Lizard, G. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105870 · Cited by 32
Moritz, E., Wegner, D., Groß, S., Bahls, M., Dörr, M., Felix, S. B., Ittermann, T., Oswald, S., Nauck, M. A., Friedrich, N., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.01.029 · Cited by 30
Inoue, T., Kohno, M., Nagahara, H., Murakami, K., Sagawa, T., Kasahara, A., Kaneshita, S., Kida, T., Fujioka, K., Wada, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218090 · Cited by 29
Self-citationZahiri, D., Burow, P., Großmann, C., Müller, C. E., Klapperstück, M., & Markwárdt, F. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118915 · Cited by 31
Motyl, J. A., Strosznajder, J. B., Wencel, A., & Strosznajder, R. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126277 · Cited by 29
Liu, H., Jin, H., Yue, X., Han, J., Baum, P., Abendschein, D. R., & Tu, Z. (2017) · Molecular Imaging · doi:10.1177/1536012116689770 · Cited by 28
“Specific S1PR1 antagonism blocked neutrophil infiltration, whereas S1PR1 agonism increased sensitivity.(21) The immunofluorescence Figure 4.”
BackgroundKleinwort, A., Lührs, F., Heidecke, C.-D., Lipp, M., & Schulze, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020391 · Cited by 28
“The crucial regulatory role of S1P has been shown in the immune system (reviewed in [5,6]),”
BackgroundMyeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation
Tsai, H., Nguyen, K. D., Hashemi, E., Engleman, E. G., Hla, T., & Han, M. H. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.06.001 · Cited by 28
Self-citationSphingolipids and impaired hypoxic stress responses in Huntington disease
Burtscher, J., Pepe, G., Maharjan, N., Riguet, N., Pardo, A. D., Maglione, V., & Millet, G. P. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101224 · Cited by 28
Kim, D., Tian, W., Wu, T.-H., Xiang, M., Vinh, R., Chang, J., Gu, S., Lee, S., Zhu, Y., Guan, T., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064181 · Cited by 29
S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis
Fang, C., Bian, G., Ren, P., Xiang, J., Song, J., Yu, C., Zhang, Q., Liu, L., Chen, K., Liu, F., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701116r · Cited by 27
Tsui, J. H., Janebodin, K., Ieronimakis, N. M., Yama, D. M. P., Yang, H. S., Chavanachat, R., Hays, A. L., Lee, H., Reyes, M., & Kim, D. (2017) · ACS Nano · doi:10.1021/acsnano.7b00186 · Cited by 27
Lipid in microglial biology — from material to mediator
Yamamoto, S., & Masuda, T. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00289-z · Cited by 28
“These bioactive mediators are well characterized in previous studies [2, 13, 51, 58].”
BackgroundRajan, S., Sood, A., Jain, R., Tryphena, K. P., & Khatri, D. K. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137596 · Cited by 28
Houck, J. D., Dawson, T. K., Kennedy, A. J., Kharel, Y., Naimon, N. D., Field, S. D., Lynch, K. R., & Macdonald, T. L. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00002 · Cited by 26
Gilmore, J. L., Sheppeck, J. E., Watterson, S. H., Haque, L., Mukhopadhyay, P., Tebben, A. J., Galella, M. A., Shen, D. R., Yarde, M., Cvijic, M. E., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00373 · Cited by 26
Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
Cooper, A. G., Singh, S., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013243 · Cited by 31
“Development of synthetic S1P receptor ligands has been most intensive for S1P1 receptor; however, selective agonists and some antagonists of other S1P receptors have been reported and reviewed elsewhere (Blaho and Hla, 2014; Delgado and Martínez-Cartro, 2016).”
BackgroundDiscovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1
Bell, M. E., Foley, D., Naylor, C., Robinson, C., Riley, J., Epemolu, O., Scullion, P., Shishikura, Y., Katz, E., McLean, W. H. I., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.07.044 · Cited by 26
Kihara, Y., & Chun, J. J. M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108432 · Cited by 29
Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer
Meshcheryakova, A., Svoboda, M., Jaritz, M., Mungenast, F., Salzmann, M., Pils, D., Castillo‐Tong, D. C., Hager, G., Wolf, A. M., Braicu, E. I., et al. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.04.004 · Cited by 28
“(II) S1P gradient and S1P/ S1P receptor axis represents an obligatory signal for trafficking of immune cells [28].”
BackgroundIn vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation
Liu, H., Luo, Z., Gu, J., Jiang, H., Joshi, S., Shoghi, K. I., Zhou, Y., Gropler, R. J., Benzinger, T. L. S., & Tu, Z. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01514-8 · Cited by 27
Zeraatpisheh, Z., Mirzaei, E., Nami, M., Alipour, H., Mahdavipour, M., Sarkoohi, P., Torabi, S., Azari, H., & Aligholi, H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15391 · Cited by 25
Anti-leukemic activity of a four-plant mixture in a leukemic rat model
Kabeel, M. M., Ghoneim, A., & Mansy, S. E. (2018) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-018-0019-5 · Cited by 27
“Expression of S1PR by blood cancer cells may directly regulate their survival by controlling the localization of cells within permissive environments such as the lymph nodes (Blaho & Hla, 2014).”
S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes
He, Q., Bo, J., Shen, R., Li, Y., Zhang, Y., Zhang, J., Yang, J., & Liu, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1341750 · Cited by 26
“(1) Mainly expressed in lymphoid tissue, lungs, the brain (especially oligodendrocytes), white blood cells, and the spleen [117].”
BackgroundIhlefeld, K., Vienken, H., Claas, R. F., Blankenbach, K. V., Rudowski, A., ter Braak, M., Koch, A., Veldhoven, P. P. V., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m052761 · Cited by 27
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.